These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7996433)

  • 1. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.
    Meller E; Bohmaker K
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of 5-HT1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine: evidence for gender differences.
    Battaglia G; Cabrera TM
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1453-61. PubMed ID: 7996458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT.
    Faure C; Mnie-Filali O; Scarna H; Debonnel G; Haddjeri N
    Neurosci Lett; 2006 Aug; 404(1-2):122-6. PubMed ID: 16759802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA; Chou JM; Tang H; Frazer A
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
    Bervoets K; Millan MJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
    Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K; Rivet JM; Millan MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    Synapse; 1997 Feb; 25(2):107-16. PubMed ID: 9021891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.